Functionalized oligomers

US9598549B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9598549-B2
Application numberUS-201314427013-A
CountryUS
Kind codeB2
Filing dateSep 16, 2013
Priority dateSep 28, 2012
Publication dateMar 21, 2017
Grant dateMar 21, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments of the present disclosure are directed towards functionalized oligomers. As an example, a functionalized oligomer can be represented of Formula (I): (Formula I) in which R 1 is a structure of Formula II: (Formula II) and R 2 has a formula —CxHyO—, wherein n is an integer having a value from 2 to 6, m is an integer having a value from 2 to 10, X independently is an integer having a value from 1 to 12, and Y is an integer having a value from 2 to 24.

First claim

Opening claim text (preview).

What is claimed: 1. A functionalized oligomer of Formula (I): in which R 1 is a structure of Formula IV: and R 2 has a formula —C X H Y O—, wherein n has a value of 2, m is an integer having a value from 3 to 4, b has a value of 3 to 4, X has a value of 2, and Y has a value of 4. 2. An open-cell foam forming composition comprising: a functionalized oligomer of claim 1 ; and a multifunctional Michael acceptor. 3. The composition of claim 2 , wherein the functionalized oligomer has an equivalent weight of 200 grams/equivalent to 5000 grams/equivalent. 4. The composition of claim 2 , wherein the multifunctional Michael acceptor is a multifunctional acrylate. 5. The composition of claim 4 , wherein the multifunctional acrylate is selected from the group of trimethyloipropanetri-acrylate, pentaerythritoltetra-acrylate, di-trimethylolpropanetertra-acrylate, di-pentaerythritolhexa-acrylate, di-pentaerthritolpenta-acrylate, diacrylate of diglycidyl ether bisphenol-A, ethoxylated trimethylolpropane triacrylate, tricyclodecanedimethanol diacrylate, cyclohexanedimethanol diacrylate, and combinations thereof. 6. The composition of claim 2 , wherein multifunctional Michael acceptor functionalities and functionalized oligomer functionalities have a molar ratio of 0.5:3.0 to 3.0:0.5 moles of multifunctional Michael acceptor functionalities to moles of the functionalized oligomer functionalities. 7. The composition of claim 2 , including a catalyst having a concentration of 0.01 moles of catalyst per equivalent of functionalized oligomer functionalities percent to 1 mole of catalyst per equivalent of functionalized oligomer functionalities. 8. The composition of claim 7 , wherein the catalyst is selected from the group of 1,1,3,3-tetramethylguanidine, 1,8-diazabicyclo[5.4.0]undec-7-ene, 1,5-diazabicyclo[4.3.0]non-5-ene, tetramethylammonium hydroxide, (2-hydroxyethyl)trimethylammonium hydroxide, potassium carbonate, potassium phosphate, potassium phenoxide, sodium phenoxide, tertraethylammonium hydroxide, and combinations thereof. 9. The composition of claim 2 , including a blowing agent having a concentration of 0.5 weight percent to 50 weight percent based upon a total weight of the functionalized oligomer and the multifunctional Michael acceptor. 10. The composition of claim 9 , wherein the blowing agent is selected from the group of cyclopentane, n-pentane, formaldehyde dimethylacetal, methylformate, methyl butane, 1,1,2,2,3-pentafluoropropane, 1,1,1,3,3-pentafluoropropane, 1,1,1,3,3-pentafluorobutane, 1,1,1,2,3,4,4,5,5,5-decafluoropentane, and combinations thereof. 11. The composition of claim 2 , including a surfactant having a concentration of 0.1 weight percent to 5.0 weight percent based upon a total weight of the functionalized oligomer and the multifunctional Michael acceptor. 12. An open-cell foam that is a reaction product of open-cell foam forming composition of claim 2 .

Assignees

Inventors

Classifications

  • C08J9/141Primary

    Hydrocarbons · CPC title

  • Halogenated saturated hydrocarbons, e.g. H3C-CF3 · CPC title

  • Polyalkylene oxides · CPC title

  • branched · CPC title

  • C08J9/147Primary

    containing carbon and halogen atoms only · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9598549B2 cover?
Embodiments of the present disclosure are directed towards functionalized oligomers. As an example, a functionalized oligomer can be represented of Formula (I): (Formula I) in which R 1 is a structure of Formula II: (Formula II) and R 2 has a formula —CxHyO—, wherein n is an integer having a value from 2 to 6, m is an integer having a value from 2 to 10, X independently is an integer having a…
Who is the assignee on this patent?
Dow Global Technologies Llc
What technology area does this patent fall under?
Primary CPC classification C08J9/141. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).